Citation Resources strikes more oil in Guatemala

Published 30-APR-2014 14:33 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Citation Resources Ltd (ASX: CTR) has struck what it calls a ‘significant oil show’ at its Atzam #5 well in the South Peten Basin in Guatemala. It successfully drilled to its planned depth of 4,025ft and intersected with other reservoirs in the structure.

Drilling analysis

The Atzam #5 well has been confirmed at total depth as being structurally high when compared to Atzam #4 and #2, with an initial flow rate of more than 1,000bpd.

CTR has now begun to evaluate the primary carbonate reservoir sections from the drill and will begin a flow testing programme shortly across all of its carbonate reservoir sections identified in Atzam #5.

Atzam #5 was drilled to its second casing point and CTR says multiple pay zones for oil and gas have been identified, further indicating there are plenty of resources to tap in the area.

CTR’s technology provider Schlumberger is due to analyse the electric logs produced from the drillings with early indications showing there are highly fractured potential reservoir sections at the location.

The operator of the site, Latin American Resources – of which CTR has acquired a 60% interest – has already conducted a preliminary analysis of the carbonate sections that have been drilled. CTR says these have shown ‘very encouraging results.’

Atzam #5 well

CTR says its carbonate sections drilled in the Atzam #5 well are now around the same depth as its Atzam #4 well, which is located 1.2km away.

The company plans to further investigate the ‘structural extent and volumetrics’ of the Atzam Oil Field through a 3D seismic survey that is scheduled to begin this year after the drilling of Atzam #5.

The well at Atzam #2 is flowing at a rate of over 1,000bpd and CTR is hoping the newly drilled Atzam #5 can match or even exceed that rate. Both wells are targeting the same primary carbonates.

South Peten Basin in Guatemala

The Atzam Oil Project in the South Peten Basin began last year after Latin American Resources started flow testing operations on the Atzam #4 well, discovering an average rate of 610bpd.

The solid flow rate of this well and the quality of its oil encouraged CTR to expand its efforts and spud Atzam #5.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free